Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2026-05-15 @ 2:28 PM
Study NCT ID:
NCT04480333
Status:
UNKNOWN
Last Update Posted:
2020-07-21
First Post:
2020-07-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
Sponsor:
Biomed Industries, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NEUROSIVIR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None